Genomictree Inc. (228760.KQ)
KRW 23550.0
(3.06%)
KRW 23550.0
(3.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1.03 Billion KRW | -104.32% |
| 2022 | 24.02 Billion KRW | 1282.67% |
| 2021 | 1.73 Billion KRW | 382.3% |
| 2020 | -615.57 Million KRW | 15.49% |
| 2019 | -728.38 Million KRW | -312.58% |
| 2018 | -176.54 Million KRW | -35.05% |
| 2017 | -130.72 Million KRW | -2650.61% |
| 2016 | 5.12 Million KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -673.05 Million KRW | -80.82% |
| 2024 Q2 | -262.82 Million KRW | 86.84% |
| 2023 Q1 | 10.55 Million KRW | -97.93% |
| 2023 Q4 | -372.21 Million KRW | 38.82% |
| 2023 FY | -1.03 Billion KRW | -104.32% |
| 2023 Q2 | -73.13 Million KRW | -792.86% |
| 2023 Q3 | -608.42 Million KRW | -731.96% |
| 2022 Q2 | 172.8 Million KRW | -99.24% |
| 2022 FY | 24.02 Billion KRW | 1282.67% |
| 2022 Q4 | 509.42 Million KRW | -24.08% |
| 2022 Q3 | 671.03 Million KRW | 288.31% |
| 2022 Q1 | 22.67 Billion KRW | 1659.17% |
| 2021 FY | 1.73 Billion KRW | 382.3% |
| 2021 Q3 | -745.7 Million KRW | 0.0% |
| 2021 Q4 | 1.28 Billion KRW | 272.85% |
| 2020 FY | -615.57 Million KRW | 15.49% |
| 2019 FY | -728.38 Million KRW | -312.58% |
| 2018 FY | -176.54 Million KRW | -35.05% |
| 2017 FY | -130.72 Million KRW | -2650.61% |
| 2016 FY | 5.12 Million KRW | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| HLB Co., Ltd. | -6.01 Billion KRW | 82.726% |
| iNtRON Biotechnology, Inc. | 4.56 Billion KRW | 122.772% |
| BINEX Co., Ltd. | 56.65 Billion KRW | 101.833% |
| Bioneer Corporation | 199.25 Billion KRW | 100.521% |
| Anterogen.Co.,Ltd. | 2.21 Billion KRW | 146.922% |
| MEDIPOST Co., Ltd. | 40.18 Billion KRW | 102.585% |
| CrystalGenomics, Inc. | 1.45 Billion KRW | 171.283% |
| Helixmith Co., Ltd | 2.12 Billion KRW | 148.948% |
| Chabiotech Co.,Ltd. | 255.19 Billion KRW | 100.407% |
| Medy-Tox Inc. | 128.16 Billion KRW | 100.81% |
| Peptron, Inc. | 1.14 Billion KRW | 191.058% |
| Amicogen, Inc. | 51.51 Billion KRW | 102.016% |
| Genexine, Inc. | 387.48 Million KRW | 368.035% |
| HLB Therapeutics Co.,Ltd. | 6.69 Billion KRW | 115.515% |
| LegoChem Biosciences, Inc. | 17.79 Billion KRW | 105.836% |
| ALTEOGEN Inc. | 31.19 Billion KRW | 103.329% |
| PharmaResearch Co., Ltd. | 182.25 Billion KRW | 100.57% |
| SillaJen, Inc. | 1.45 Billion KRW | 171.296% |
| JETEMA, Co., Ltd. | 26.58 Billion KRW | 103.907% |
| OliX Pharmaceuticals,Inc | 14.42 Billion KRW | 107.201% |
| MedPacto, Inc. | -1.83 Billion KRW | 43.329% |
| D&D Pharmatech | 18.67 Billion KRW | 105.561% |
| EASY BIO,Inc. | 50.88 Billion KRW | 102.041% |
| GI Innovation, Inc. | 1.98 Billion KRW | 152.206% |